SM

Stanislas Mayer

DS Domain Therapeutics Sa: 4 patents #1 of 10Top 10%
CT Cv Therapeutics: 1 patents #50 of 71Top 75%
Merck: 1 patents #5,419 of 9,382Top 60%
📍 Plobsheim, FR: #2 of 14 inventorsTop 15%
Overall (All Time): #594,182 of 4,157,543Top 15%
8
Patents All Time

Issued Patents All Time

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
12194051 5-azaindazole derivatives as adenosine receptor antagonists Anne-Laure Blayo, Baptiste MANTEAU, Camille AMALRIC, Stephan Schann, Mickaël FER 2025-01-14
11472806 Substituted heterocyclic compounds as allosteric modulators of group II metabotropic glutamate receptors Anne-Laure Blayo, Thomas CATELAIN, Ismet Dorange, Cédric Genet, Baptiste MANTEAU +1 more 2022-10-18
11008323 Substituted tricyclic 1,4-benzodiazepinone derivatives as allosteric modulators of group II metabotropic glutamate receptors Stephan Schann, Baptiste MANTEAU 2021-05-18
10221179 Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group II metabotropic glutamate receptors Stephan Schann, Baptiste MANTEAU 2019-03-05
9434734 Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group II metabotropic glutamate receptors Stephan Schann 2016-09-06
9029393 Adenosine receptor ligands and uses thereof Stephan Schann 2015-05-12
8962627 Oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptors Stephan Schann, Christophe Morice, Bruno Giethlen 2015-02-24
7300923 Partial and full agonists of A1 adenosine receptors Jeff Zablocki, Elfatih Elzein, Michael Organ, Yaroslav Bilokin, Anthony Disanti +2 more 2007-11-27